Novadaq Technologies Inc. develops, manufactures, and commercializes fluorescence imaging technology products and therapeutic devices for surgeons in the operating room and other clinical settings primarily in the United States and Japan. The company’s proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. It provides SPY imaging systems, which allow surgeons to capture, review, print, and archive image sequences of blood flow in vessels and micro-vessels, tissues, and organ perfusion in real-time during the course of performing various surgical procedures; SPY-Q analysis toolkit, a post-processing software that allows surgeons to apply objective analysis tools to SPY images; and SPY Elite, which allows gastrointestinal surgeons to visualize and objectively analyze perfusion in the upper and lower gastrointestinal tract. The company also offers PINPOINT endoscopic fluorescence imaging systems that combines fluorescence imaging capabilities of SPY imaging with the HD visible light imaging capabilities of a traditional endoscopic imaging system; FireFly Systems for robotic surgery; and CO2 heart laser systems, including CO2 heart laser mobile console and CO2 heart laser disposable hand pieces for transmyocardial revascularization. Novadaq Technologies Inc. was incorporated in 2000 and is headquartered in Mississauga, Canada.